We’re taking the final two weeks of the year off for MedHeads, MedCityNews.com’s weekly video podcast looking at the business of innovation in healthcare. Instead, we’ll take the final two weeks to look at the best of Year 1 of our broadcast.
So enjoy a replay of our best MedHeads of the year: our interview with Martin Shkreli in the midst of his first controversy over the dramatic increase of Daraprim.
FierceBiotech Editor John Carroll, Timmerman Report founder Luke Timmerman and MedCity News’ biotech-pharma reporter Meghana Keshavan joined me in a discussion with Shkreli, who apologized for nothing, ripped the traditional industry leaders as hypocrites, and dodged any specifics (at the time) of lower prices and what would come next.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
I re-watched it and was amazed at – as outrageous as we thought he was then – how much further he went after this.
Photo: Big Stock Photos
